|
|
|
|
Prevention from Doxorubicin Cardiotoxicity by Available Protective Agents in Iran
|
|
|
|
|
|
|
|
نویسنده
|
Shahriari M ,Abdolkarimi B
|
|
منبع
|
iranian journal of blood and cancer - 2014 - دوره : 7 - شماره : 1 - صفحه:43 -44
|
|
چکیده
|
Doxorubicin, used in pediatric chemotherapy regimens, has cardiotoxic effects. dexrazoxane is co- administrated with doxorubicin to prevent its cardiotoxicity. here we have explored some alternative food or drugs to be used in absence of dexrazoxane since it’s not readily available in iran at this time.
|
|
کلیدواژه
|
Pediatric ,chemotherapy ,doxorubicin ,cardiotoxicity ,dexrazoxane ,Iran
|
|
آدرس
|
shiraz university of medical sciences, Department of Pediatrics, ایران, shiraz university of medical sciences, Department of Pediatrics, ایران
|
|
پست الکترونیکی
|
b.abdolkarimi@yahoo.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|